Successful treatment of dandruff with 1.5% ciclopirox olamine shampoo in Korea

BACKGROUND: Dandruff is a chronic scalp condition characterized by scaling. The common causative agent is now accepted to be the lipophilic yeast Malassezia furfur. Ketoconazole, a highly effective antifungal agent against M. furfur has been used for the treatment of dandruff. AIM: To determine whether a 1.5% ciclopirox olamine shampoo is as effective as a 2% ketoconazole shampoo for the treatment of mild to moderate dandruff. METHODS: A total of 64 patients, with mild to moderate dandruff, participated in the study. The study consisted of three consecutive phases: a 2‐week washout period, a 4‐week treatment period and a 2‐week post‐treatment period. Patients were randomized equally to either the 1.5% ciclopirox olamine shampoo or 2% ketoconazole shampoo. An overall dandruff score was calculated using an area of dandruff involvement score and a severity score. Patients evaluated the presence of pruritus and also reported a global evaluation of efficacy. RESULTS: In all, 57 patients successfully completed all three phases. The overall dandruff score declined progressively throughout the treatment period for both shampoos. A slight increase in pruritus was observed in the ciclopirox olamine treatment group during the post‐treatment phase. Regarding global self‐assessment of efficacy, both treatment groups were pleased with their scalp condition following treatment. CONCLUSION: Ciclopirox olamine shampoo appears to offer an effective, safe and easy to use treatment for mild to moderate dandruff.

[1]  G. Bulmer,et al.  The antifungal action of dandruff shampoos , 2004, Mycopathologia.

[2]  Aditya K. Gupta,et al.  Ciclopirox: an overview , 2001, International journal of dermatology.

[3]  O. Chosidow,et al.  Randomized, placebo‐controlled, double‐blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrhoeic dermatitis , 2001, The British journal of dermatology.

[4]  G. Donnarumma,et al.  New Strategies in Dandruff Treatment: Growth Control of Malassezia ovalis , 2000, Dermatology.

[5]  A. Gupta Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States. , 2000, Journal of the American Academy of Dermatology.

[6]  Lodén,et al.  The antidandruff efficacy of a shampoo containing piroctone olamine and salicylic acid in comparison to that of a zinc pyrithione shampoo , 2000, International journal of cosmetic science.

[7]  H. Degreef,et al.  From Axioms to New Insights into Dandruff , 2000, Dermatology.

[8]  I. Orengo,et al.  Anti‐inflammatory activity of antifungal preparations , 1997, International journal of dermatology.

[9]  U. Richarz-Barthauer,et al.  Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double‐blind, placebo‐controlled trial , 1995, The British journal of dermatology.

[10]  D. Rosenthal,et al.  A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. , 1993, Journal of the American Academy of Dermatology.

[11]  T. Hoehler,et al.  Ciclopirox olamine: a hydroxypyridone antifungal agent. , 1991, Clinics in dermatology.

[12]  H. Yan,et al.  A clinical and laboratory study of ciclopirox olamine (8% Batrafen) in the treatment of onychomycosis. , 1991, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[13]  C. Savopoulos,et al.  Comparison of ciclopirox olamine 1% cream with ciclopirox 1%-hydrocortisone acetate 1% cream in the treatment of inflamed superficial mycoses. , 1988, Clinical therapeutics.

[14]  S. Oliveri,et al.  Ciclopiroxolamine: clinical and microbiological considerations. Preliminary data. , 1986, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

[15]  R. N. Brogden,et al.  Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use. , 1985, Drugs.

[16]  S. Shuster THE AETIOLOGY OF DANDRUFF AND THE MODE OF ACTION OF THERAPEUTIC AGENTS , 1984, The British journal of dermatology.

[17]  E. Drouhet,et al.  Treatment of pityriasis capitis (dandruff) with econazole nitrate. , 1977, Acta dermato-venereologica.

[18]  V. N. Sehgal,et al.  Ciclopirox: a new topical pyrodonium antimycotic agent , 1976, The British journal of dermatology.